BioVinc has formed a collaboration with PharmaLegacy Laboratories, a preclinical Contract Research Organization (CRO) located in Zhangjiang High Tech Industrial Park, Shanghai, China. PharmaLegacy provides specialty pharmacology services in Inflammation/Auto-Immune Diseases, Liver/Metabolic Diseases, Bone/Orthopaedics, and Oncology. The strategic collaboration will leverage the complementary expertise from both companies in bone-related chemical reagent development and specialized animal disease models, which will better serve customers in their imaging and preclinical study needs. BioVinc highly recommends that its customers utilize PharmaLegacy when they need Contract Research Services given PharmaLegacy’s pharmacology expertise and their experience with the BioVinc fluorescent probes.

For more information about Pharmalegacy, please visit http://www.pharmalegacy.com/.